An investigation of the effects of oral neomycin on intestinal absorption and serum cholesterol levels in the dog.
D000284:Administration, Oral; D000818:Animals; D001798:Blood Proteins; D002784:Cholesterol / Q000097:blood*; D004041:Dietary Fats; D004285:Dogs; D005243:Feces / Q000032:analysis; D005696:Galactosidases / Q000032:analysis; D005959:Glucosidases / Q000032:analysis; D007408:Intestinal Absorption / Q000187:drug effects*; D007413:Intestinal Mucosa; D007422:Intestines / Q000033:anatomy & histology / Q000201:enzymology; D009355:Neomycin / Q000008:administration & dosage / Q000494:pharmacology*; D013393:Sucrase / Q000032:analysis; D014994:Xylose / Q000378:metabolism
D001798:Blood Proteins; D004041:Dietary Fats; D002784:Cholesterol; D014994:Xylose; D005696:Galactosidases; D005959:Glucosidases; D013393:Sucrase; D009355:Neomycin